StockData
Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc. (TMCI) stock

TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.44+0.02 (+0.45%)

Close on Nov 17, 2026Market cap $288.75MP/E –Yield –

Treace Medical Concepts operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Treace Medical Concepts's operating cash flow for the twelve months ending Jun 30, 2026 was -$14.58M. For fiscal 2025 it was -$15.97M. The highest annual figure on record is -$4.49M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.97M–
FY2024Dec 31, 2024-$37.17M–
FY2023Dec 31, 2023-$34.58M–
FY2022Dec 31, 2022-$30.65M–
FY2021Dec 31, 2021-$17.19M–
FY2020Dec 31, 2020-$4.49M–
FY2019Dec 31, 2019-$7.67M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.70M–
Q1 FY2026Mar 31, 2026$7.24M+72.5%
Q4 FY2025Dec 31, 2025-$8.03M–
Q3 FY2025Sep 30, 2025-$9.09M–
Q2 FY2025Jun 30, 2025-$3.05M–
Q1 FY2025Mar 31, 2025$4.20M–
Q4 FY2024Dec 31, 2024-$4.21M-890.8%
Q3 FY2024Sep 30, 2024-$11.84M–
Q2 FY2024Jun 30, 2024-$13.90M–
Q1 FY2024Mar 31, 2024-$7.22M–
Q4 FY2023Dec 31, 2023$532.00K–
Q3 FY2023Sep 30, 2023-$9.51M–
Q2 FY2023Jun 30, 2023-$8.34M–
Q1 FY2023Mar 31, 2023-$17.26M–
Q4 FY2022Dec 31, 2022-$5.36M–
Q3 FY2022Sep 30, 2022-$7.48M–
Q2 FY2022Jun 30, 2022-$10.57M–
Q1 FY2022Mar 31, 2022-$7.24M–
Q4 FY2021Dec 31, 2021-$3.75M-253.3%
Q3 FY2021Sep 30, 2021-$9.26M–
Q2 FY2021Jun 30, 2021-$3.73M–
Q1 FY2021Mar 31, 2021-$446.00K–
Q4 FY2020Dec 31, 2020$2.45M–
Q3 FY2020Sep 30, 2020-$4.20M–
Q2 FY2020Jun 30, 2020-$1.85M–
Q1 FY2020Mar 31, 2020-$895.00K–

More Treace Medical Concepts figures

See a number that looks wrong?